Business Description
Compass Pathways PLC
ISIN : US20451W1018
Share Class Description:
FRA:5Y6: ADRTotal Employee Number:
156Description
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 8.74 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | -0.3 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -12.6 | |||||
3-Year EPS without NRI Growth Rate | 5.8 | |||||
3-Year FCF Growth Rate | 12.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 21.23 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 39.99 | |||||
9-Day RSI | 46.23 | |||||
14-Day RSI | 49.52 | |||||
3-1 Month Momentum % | 104.64 | |||||
6-1 Month Momentum % | 56.45 | |||||
12-1 Month Momentum % | 212.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.32 | |||||
Quick Ratio | 3.32 | |||||
Cash Ratio | 3.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -31.1 | |||||
Shareholder Yield % | -8.19 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -133.54 | |||||
ROA % | -55.51 | |||||
ROIC % | -125.23 | |||||
3-Year ROIIC % | -38.52 | |||||
ROC (Joel Greenblatt) % | -5517.35 | |||||
ROCE % | -93.04 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 5.53 | |||||
Price-to-Tangible-Book | 5.52 | |||||
EV-to-EBIT | -7.89 | |||||
EV-to-EBITDA | -7.9 | |||||
EV-to-Forward-EBITDA | -6.93 | |||||
EV-to-FCF | -8.74 | |||||
| Price-to-Net-Current-Asset-Value | 5.9 | |||||
| Price-to-Net-Cash | 6.94 | |||||
Earnings Yield (Greenblatt) % | -12.67 | |||||
FCF Yield % | -8.83 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Compass Pathways PLC Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -2.695 | ||
| Beta | 4.1249 | ||
| 3-Year Sharpe Ratio | 0.56 | ||
| 3-Year Sortino Ratio | 0.98 | ||
| Volatility % | 90.78 | ||
| 14-Day RSI | 49.52 | ||
| 14-Day ATR (€) | 0.803113 | ||
| 20-Day SMA (€) | 11.5 | ||
| 12-1 Month Momentum % | 212.9 | ||
| 52-Week Range (€) | 3 - 13.3 | ||
| Shares Outstanding (Mil) | 134.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Compass Pathways PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Compass Pathways PLC Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-04 08:00 | In 112 days | ||
| Third quarter earnings results for 2026 | 2026-11-04 | In 111 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-31 08:00 | In 16 days | ||
| Second quarter earnings results for 2026 | 2026-07-31 | In 15 days | ||
| Jefferies Global Healthcare Conference | 2026-06-03 12:45 | 11.70 (-3.31%) | ||
| General meeting for 2026 | 2026-05-27 08:30 | 10.20 (-1.92%) | ||
| RBC Capital Markets Global Healthcare Conference | 2026-05-19 10:00 | 9.25 (-3.14%) | ||
| First quarter earnings conference call for 2026 | 2026-05-13 08:00 | 8.00 (-1.84%) | ||
| First quarter earnings results for 2026 | 2026-05-13 | 8.00 (-1.84%) | ||
| Needham Virtual Healthcare Conference | 2026-04-14 12:45 | 4.62 (+0.43%) |
Show
Entries
Compass Pathways PLC Frequently Asked Questions
What is Compass Pathways PLC(FRA:5Y6)'s stock price today?
The current price of FRA:5Y6 is €11.10. The 52 week high of FRA:5Y6 is €13.30 and 52 week low is €3.00.
When is next earnings date of Compass Pathways PLC(FRA:5Y6)?
The next earnings date of Compass Pathways PLC(FRA:5Y6) is 2026-07-31 Est..
Does Compass Pathways PLC(FRA:5Y6) pay dividends? If so, how much?
Compass Pathways PLC(FRA:5Y6) does not pay dividend.
Press Release
Articles on Compass Pathways PLC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers